Intellectual Property India Publishes Patent Application for 'Enhanced Nad+ Compositions And Methods Of Making And Using The Same' Filed by Bionadrx Holdings, Inc.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517046858 A) filed by Bionadrx Holdings, Inc., Johnson City, U.S.A., on May 15, for 'enhanced nad+ compositions and methods of making and using the same.'

Inventor(s) include Latham, Keith, R.; Garland, Regina, L.; and Komac, Wendy.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides enhanced nicotinamide adenine dinucleotide (NAD+) compositions and pharmaceutical formulations, useful in the treatment of disorders and diseases regulated by deficiencies in NAD+, and methods of preparation and use of the same."

The patent application was internationally filed on Oct. 19, 2023, under International application No.PCT/US2023/035557.

Disclaimer: Curated by HT Syndication.